HSA-/PLGA-nanoparticles as diagnostic markers for hepatocellular carcinoma (HCC)
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. For curative treatment options, early diagnosis is crucial. In this context, the present invention provides a new contrast agent, made of Gd-DTPA-loaded HSA-/PLGA-nanoparticles for magnetic resonance imaging (MRI) enabling the detection of small HCC which are undetectable with current methods and improving differentiation between HCC and benign lesions in the cirrhotic lever.
Further Information: PDF
INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0
Contact
Dr. Otmar Schöller
Media Contact
All latest news from the category: Technology Offerings
Newest articles
New theory reveals the shape of a single photon
A new theory, that explains how light and matter interact at the quantum level has enabled researchers to define for the first time the precise shape of a single photon….
Perovskite research boosts solar cell efficiency and product life
An international team led by the University of Surrey with Imperial College London have identified a strategy to improve both the performance and stability for solar cells made out of…
Neuroscientists discover how the brain slows anxious breathing
Salk scientists identify brain circuit used to consciously slow breathing and confirm this reduces anxiety and negative emotions. Deep breath in, slow breath out… Isn’t it odd that we can…